Bruker is excited to attend the TIDES Asia 2026, Asia's Premier Forum Accelerating Therapeutic Breakthroughs from Discovery to Market. Dive into cutting-edge research, share insights withthe leaders in oligonucleotide, peptide, mRNA, and genome editing converge to share cutting-edge strategies across discovery, development, and CMC - advancing next-generation therapeutics through collaborative innovation
Join us at our booth #9!
Bruker Presentation
- Date: Thursday, 26 Feb
- Time: 2:15 - 2:45 p.m.
- Title: Unlocking the Structural Complexity of TIDES with Advanced NMR Spectroscopy
- Abstract: Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful and versatile tool for structural characterization, offering atomic-level resolution, sensitivity to subtle (stereo)chemical differences, and inherently quantitative data. As the spotlight in biopharma shifts toward complex modalities like peptides and antisense oligonucleotides (ASOs)—collectively referred to as TIDES—NMR is stepping into a critical role in revealing their structural and chemical intricacies. In this presentation, we’ll explore how NMR, empowered by technologies like the MNI probe, is unlocking deeper understanding of peptide and ASO therapeutics. We'll share real-world case studies that demonstrate how NMR delivers actionable insights, supports regulatory expectations, and drives innovation across the TIDES landscape.
- Speaker: Dr. Shubhadra Pillay, Solutions Product Manager / TIDES Solutions Product Manager, Bruker BioSpin
